Inventor · disambiguated record
Peisheng Hu
Also filed as: HU PEISHENG
13 granted patents·16 pending applications·194 citations·filing 1990–2025
92Inventor score
Files withUNIV SOUTHERN CALIFORNIA18EPSTEIN ALAN L5CANCER THERAPEUTICS LABORATORIES INC3BIOMED INC Z1UNIV VIRGINIA COMMONWEALTH1
Top patents by PatentIndex Score
29 records- 0197US7514073B2Therapeutic use of interleukin-2 mutantsUNIV SOUTHERN CALIFORNIA·Filed 2005·Granted Apr 7, 2009·49 cites·7 claims
- 0296US8124066B2Methods of using interleukin-2 mutants with reduced toxicityEPSTEIN ALAN L·Filed 2010·Granted Feb 28, 2012·37 cites·12 claims
- 0395US7803361B2Therapeutic use of interleukin-2 mutantsUNIV SOUTHERN CALIFORNIA·Filed 2009·Granted Sep 28, 2010·31 cites·8 claims
- 0495US7371371B2Interleukin-2 mutants with reduced toxicityUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted May 13, 2008·59 cites·11 claims
- 0589US12258421B2Humanized anti-nuclear antibodies for targeting necrosis in cancer therapyCANCER THERAPEUTICS LABORATORIES INC·Filed 2022·Granted Mar 25, 2025·1 cites·17 claims
- 0684US2024392011A1Hla-g as a novel target for car t-cell immunotherapyUNIV SOUTHERN CALIFORNIA·Filed 2024·Application pending·0 cites
- 0784US2025129171A1Car t-cell therapy directed to lhr for the treatment of solid tumorsUNIV SOUTHERN CALIFORNIA·Filed 2024·Application pending·0 cites
- 0881US11384157B2Humanized anti-nuclear antibodies for targeting necrosis in cancer therapyCANCER THERAPEUTICS LABORATORIES INC·Filed 2018·Granted Jul 12, 2022·1 cites·20 claims
- 0981US8545838B2Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2007·Granted Oct 1, 2013·3 cites·46 claims
- 1078US10196435B2OX40L fusion protein for the immunotherapy of tumors of veterinary animalsEPSTEIN ALAN L·Filed 2014·Granted Feb 5, 2019·2 cites·8 claims
- 1176US11136401B2Car t-cell therapy directed to LHR for the treatment of solid tumorsUNIV SOUTHERN CALIFORNIA·Filed 2016·Granted Oct 5, 2021·1 cites·16 claims
- 1273US8795672B2Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2004·Granted Aug 5, 2014·2 cites·7 claims
- 1372US2021403585A1Car t-cell therapy directed to lhr for the treatment of solid tumorsUNIV SOUTHERN CALIFORNIA·Filed 2021·Application pending·0 cites
- 1472US2024150470A1Lym-1 and lym-2 antibody compositions and improved car constructsUNIV SOUTHERN CALIFORNIA·Filed 2023·Application pending·0 cites
- 1571US11667715B2Lym-1 and Lym-2 antibody compositions and improved car constructsUNIV SOUTHERN CALIFORNIA·Filed 2021·Granted Jun 6, 2023·0 cites·30 claims
- 1668US2021070864A1Hla-g as a novel target for car t-cell immunotherapyUNIV SOUTHERN CALIFORNIA·Filed 2020·Application pending·0 cites
- 1765US2025215114A1Humanized anti-nuclear antibodies for targeting necrosis in cancer therapyCANCER THERAPEUTICS LABORATORIES INC·Filed 2025·Application pending·0 cites
- 1862US2014099305A1Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2013·Application pending·0 cites
- 1960US10961317B2CD20 scFv-ELPs methods and therapeuticsUNIV SOUTHERN CALIFORNIA·Filed 2019·Granted Mar 30, 2021·0 cites·22 claims
- 2059US2019119385A1Hla-g as a novel target for car t-cell immunotherapyUNIV SOUTHERN CALIFORNIA·Filed 2016·Application pending·0 cites
- 2157US2005201979A1Interleukin-2 mutants with reduced toxicityUNIV SOUTHERN CALIFORNIA·Filed 2005·Application pending·0 cites
- 2257US2023331849A1CpG IMMUNOCONJUGATES FOR CANCER THERAPYUNIV SOUTHERN CALIFORNIA·Filed 2021·Application pending·0 cites
- 2349US2015218280A1CD20 scFv-ELPs METHODS AND THERAPEUTICSUNIV SOUTHERN CALIFORNIA·Filed 2013·Application pending·0 cites
- 2448US2007015172A1Expression profiles for microbial infectionBIOMED INC Z·Filed 2005·Application pending·0 cites
- 2543US5427907AAssay for equine infectious anemia virusUNIV VIRGINIA COMMONWEALTH·Filed 1990·Granted Jun 27, 1995·8 cites·10 claims
- 2641US2019300619A1Gitr agonists, and methods of use thereofUNIV SOUTHERN CALIFORNIA·Filed 2019·Application pending·0 cites
- 2740US2018118831A1Car t-cells for the treatment of b7-h4 expressing solid tumorsUNIV SOUTHERN CALIFORNIA·Filed 2016·Application pending·0 cites
- 2839US2018291089A1Secretory tnt car cell immunotherapyUNIV SOUTHERN CALIFORNIA·Filed 2016·Application pending·0 cites
- 2935US2017184593A1A chronic renal disease diagnostic kitUNIV WENZHOU MEDICAL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peisheng Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →